# The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection

> **NCT02412319** · PHASE4 · UNKNOWN · sponsor: **Shineway Pharmaceutical Co.,Ltd** · enrollment: 288 (estimated)

## Conditions studied

- HBeAg Positive Chronic Hepatitis B

## Interventions

- **DRUG:** Anti-HBV placenta transfer factor injection
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02412319
- **Lead sponsor:** Shineway Pharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 288 (ESTIMATED)
- **Last updated:** 2015-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412319, "The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02412319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*